SCHEMBL5590307

SCHEMBL5590307

CCCCC(C)Oc1cccc(O)c1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
LMNA P02545 3/20 0.44
MAPT P10636 2/20 0.44
HPGD P15428 2/20 0.44
ALOX15 P16050 2/20 0.44
HSD17B10 Q99714 2/20 0.44
KDM4E B2RXH2 1/20 0.44
TP53 P04637 1/20 0.44
CYP3A4 P08684 1/20 0.44
ALOX12 P18054 1/20 0.44
MAPK1 P28482 1/20 0.44
MCHR1 Q99705 1/20 0.41
ALOX5 P09917 1/20 0.41
PTGS2 P35354 1/20 0.41
IAPP P10997 2/20 0.39
BCHE P06276 1/20 0.37
TYR P14679 1/20 0.37
ACHE P22303 1/20 0.37
GPR88 Q9GZN0 1/20 0.36
PTPN1 P18031 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5588071 0.95 ALDH1A1 (0.43) ALDH1A1LMNAMAPTHPGDALOX15
SCHEMBL5591147 0.94 ALDH1A1 (0.43) ALDH1A1LMNAMAPTHPGDALOX15
SCHEMBL5588062 0.94 ALDH1A1 (0.43) ALDH1A1LMNAMAPTHPGDALOX15
SCHEMBL5589242 0.94 ALDH1A1 (0.43) ALDH1A1LMNAMAPTHPGDALOX15
SCHEMBL5587003 0.94 ALDH1A1 (0.43) ALDH1A1LMNAMAPTHPGDALOX15
SCHEMBL5587138 0.94 ALDH1A1 (0.43) ALDH1A1LMNAMAPTHPGDALOX15
SCHEMBL5589741 0.94 ALDH1A1 (0.43) ALDH1A1LMNAMAPTHPGDALOX15
SCHEMBL5588014 0.90 MCHR1 (0.50) ALDH1A1LMNAMAPTHPGDALOX15
SCHEMBL5589919 0.85 LMNA (0.46) ALDH1A1LMNAMAPTHPGDALOX15
SCHEMBL27980864 0.83 ALDH1A1 (0.44) ALDH1A1LMNAMAPTKDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 ALDH1A1 2181/4885LMNA 178/4885MAPT 585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.